Bavarian Biotech Report 2011/2012 (7MB) - Bio M

More documents

Recommendations

Info

Contact:Dr. Lars WassillWerkstr. 2D-83555 Gars-BahnhofPhone: +49 (0) 8073 91693-0Fax: +49 (0) 8073 91693-33E-Mail: info@amplexdiagnostics.deInternet: www.amplexdiagnostics.deAmplexDiagnostics GmbH − Gesellschaftfür molekularbiologische DiagnostikBIOTECH DNA/PROTEIN ANALYTICSKeywords: Clinical Diagnostics, PCR, Infectious DiseasesAmplexDiagnostics GmbH is a privately held company for the development,production and distribution of In Vitro Diagnostics. Our aim is the improvementof the potential of the PCR-technology by implementing the mainadvantages of this technology into the diagnosis of bacterial infections.Founded in 2002 - Amplex developed its first product (hyplex © StaphyloResist)and entered the market already in 2003. Additional systems for the directdetection of multidrug-resistant bacteria (like VRE, ESBL, KPC and NDM-1)are completing our portfolio of PCR-screening tests for nosocomial infectionscausing bugs. Beside this we offer several PCR-based screening testsfor sexual transmitted diseases, EHEC or TBC. For further information pleasevisit our webpage www.hyplex.de or contact us.AMS Advanced Medical ServicesCROContact:Dr. Gerlinde JänelWerner-Eckert-Str. 10D-81829 MünchenPhone: +49 (0) 89 2000074-11Fax: +49 (0) 89 2000074-40E-Mail: gerlinde.jaenel@ams-europe.comInternet: www.ams-europe.comKeywords: Analysis, Pharmacology, Medical Writing, Monitoring, ClinicalResearchAMS Advanced Medical Services GmbH is a privately owned independentEuropean mid-size CRO founded in 1997 in Mannheim by 6 partners, 4 ofwhom are medical doctors. AMS has also offices in London, Vienna andMunich. AMS has an overall staff of 350 people, approx. half of them are inclinical research, the other half in Marketing and Sales services. AMSinvented the 1. Internet-Pharmaschool (1.IPS) with trainers and techniquesoffering tailor-made training concepts for staff in both clinical research andsales. AMS is a full service CRO with significant experience in multipletherapeutic areas and strong medical expertise covering Phase I to Phase IV,non-interventional programs, pharmaco-epidemiology and -economics.Our staff includes 60 CRAs and more than 50 people in DM and Stats.AMSilk GmbHBIOTECH AGRO, FOOD, ENVIRONMENTContact:Axel LeimerAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 38156-4430Fax: +49 (0) 89 38156-3859E-Mail: info@amsilk.comInternet: www.amsilk.comKeywords: Drug Delivery, Tissue Engineering / Cell Culture, Fine Chemicals /Reagents, New MaterialsTechnology enables the production of tailor-made materials which areunrivaled by most common synthetic materials. AMSilk addresses manyapplications and industry sectors with new materials enabling new productswith previously unachievable features.AMSilk has developed a unique process to produce biopolymers like spidersilk at an industrial scale. These materials form the basis for coatings, films,non-wovens and monofilament fibers. The resulting products are being developedmedical, pharmaceutical and industrial applications. The name AMSilkand the AMSilk Logo are registered trademarks of AMSilk GmbH; Munich.36
AmVac Research GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Vaccines, Gene Transfer, Drug DevelopmentAmVac Research is a biotech company developing highly innovative andmultifunctional vaccines. The company is using a novel viral vector technologythat combines excellent immunogenicity of live viral vaccines with thehigh safety profile of inactivated vaccines. This technology serves as aplatform for the development of several tailor-made vaccines. One mainfocus of the company is the development of vaccines against respiratorytract diseases caused by viral agents such as RSV or hPIV3 against which noeffective therapeutic or preventive means exist. Related to vaccination, AmVacis developing adjuvant candidates which show superior mucosal efficacy.R E S E A R C H G m b HContact:Dr. Marian WiegandLochhamer Str. 29aD-82152 MartinsriedPhone: +49 (0) 89 63854363Fax: +49 (0) 89 99753425E-Mail: info@amvac-research.deInternet: www.amvac-research.deamYmed GmbH −Referenzzentrum für AmyloidkrankheitenBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Antibody, Devices, Antibody Production Service, ClinicalDiagnosticsWe provide high precision immunhistochemical classification of the diverseamyloid diseases with respect to specific and causal treatment as a servicefor patients and physicians.We are in the process of extending this service by producing and offeringtest kits in order to enable clinics and institutes of pathology to perform thisclassification by themselves.Contact:Prof. Dr. med. Reinhold P. LinkeAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 5<strong>2012</strong>638Fax: +49 (0) 89 52389013E-Mail: linke@amymed.deInternet: www.amymed.deAntisense Pharma GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Oncology, Antisense/Nucleotides, RNAi & Antisense, Drug DevelopmentAntisense Pharma is a biopharmaceutical company located in Regensburg,Germany. The company focuses on targeted therapies for malignant tumorsand is dedicated to discovering and developing drugs based on antisensetechnology. The medications specifically block the synthesis of key cancerproteins. Antisense Pharma has clinical trials running that involve patientswith brain tumors (phase III), advanced pancreatic carcinoma, malignantmelanoma and colorectal carcinoma (phase I/II). Therapies for other indicationsare under preclinical development. The company has been honoredwith the German Founder Award and the <strong>Bavarian</strong> Innovation Award andreceived the Innovation Prize TOP 100 twice.Contact:Carolin NolteJosef-Engert-Str. 9D-93053 RegensburgPhone: +49 (0) 941 92013-0Fax: +49 (0) 941 92013-29E-Mail: pr@antisense-pharma.comInternet: www.antisense-pharma.com37
Page 2 and 3: Our research benefits your health.T
Page 4 and 5: ImprintEditorial staff: Georg Kää
Page 6 and 7: Select IMGM as your outsourcing par
Page 8 and 9: The 2011 Biotech Year in Bavaria -A
Page 10 and 11: Due to this focus that was establis
Page 12 and 13: Furthermore, the continued interest
Page 14 and 15: Last but not least, the IZB start-u
Page 16 and 17: Company FoundationsMerck-Sharp & Do
Page 18 and 19: Total number of employees in the Ba
Page 20 and 21: PHASE II4SC: Hepatocellular carcino
Page 22 and 23: Deals, Cooperation, Mergers, Financ
Page 24 and 25: M&A-ActivityIn early 2011 the acqui
Page 26: Due to the increasing number of new
Page 29: one so called “innovation allianc
Page 32 and 33: 4SC AGBIOTECH THERAPEUTICS & DIAGNO
Page 34 and 35: Contact:Dr. Luc St-OngeFraunhoferst
Page 38 and 39: Apceth GmbH & Co. KGBIOTECH THERAPE
Page 40 and 41: Contact:Dr. Gundel HagerBahnhofstr.
Page 42 and 43: Bernina Plus GmbHBIOTECH THERAPEUTI
Page 44 and 45: Biontex Laboratories GmbHBIOTECH DE
Page 46 and 47: Carl Zeiss MicroImaging GmbHBIOTECH
Page 48 and 49: ChemDiv, Inc.CROContact:Dr. Anna Ni
Page 50 and 51: conoGenetix biosciences GmbHBIOTECH
Page 52 and 53: CoreLab Partners Europe GmbHCROCont
Page 54 and 55: Davids Biotechnologie GmbHBIOTECH D
Page 56 and 57: Dynamic BiosensorsBIOTECH DNA/PROTE
Page 58 and 59: Contact:Uschi LangGoethestr. 4D-803
Page 60 and 61: Eurofins MWG OperonBIOTECH DNA/PROT
Page 62 and 63: FGK Clinical Research GmbHCROContac
Page 64 and 65: GeneArt AGBIOTECHContact:Prof. Dr.
Page 66 and 67: Contact:Dr. Korbinian GroteBayerstr
Page 68 and 69: Contact:Peter Paul SchikoraMühlfel
Page 70 and 71: Contact:Kurt MartinJosef-Engert-Str
Page 72 and 73: ibidi GmbHBIOTECH DEVICES & REAGENT
Page 74 and 75: Immumed GmbH -Gesellschaft für ang
Page 76 and 77: INHECO GmbHBIOTECH DEVICES & REAGEN
Page 78 and 79: IRIS Biotech GmbHPHARMA & CHEMICAL
Page 80 and 81: KLIFOVET AGCROContact:Dr. Klaus Hel
Page 82 and 83: LEUKOCARE AGBIOTECH DEVICES & REAGE
Page 84 and 85: medicomp GmbHCROContact:Dr. med. ve
Page 86 and 87:
Contact:Dr. Erwin SoutschekFlorians
Page 88 and 89:
MLL Münchner Leukämie Labor GmbHB
Page 90 and 91:
multimmune GmbHBIOTECH THERAPEUTICS
Page 92 and 93:
NanoScape AGPHARMA & CHEMICAL INDUS
Page 94 and 95:
nexttec GmbHBIOTECH DNA/PROTEIN ANA
Page 96 and 97:
Contact:Michael AlmstetterAm Klopfe
Page 98 and 99:
PAN Biotech GmbHBIOTECH DEVICES & R
Page 100 and 101:
Pharma Stulln GmbHPHARMA & CHEMICAL
Page 102 and 103:
Phytochem Referenzsubstanzen GbRmbH
Page 104 and 105:
PreSens Precision Sensing GmbHBIOTE
Page 106 and 107:
Contact:Dr. Torsten NeuefeindBunsen
Page 108 and 109:
Ridom GmbHBIOTECH BIOINFORMATICSCon
Page 110 and 111:
SERVIER Deutschland GmbHPHARMA & CH
Page 112 and 113:
SSS International Clinical Research
Page 114 and 115:
TILL Photonics GmbHBIOTECH DEVICES
Page 116 and 117:
Tripos InternationalBIOTECH BIOINFO
Page 118 and 119:
vertis Biotechnologie AGBIOTECH DNA
Page 120 and 121:
Wilex AGBIOTECH THERAPEUTICS & DIAG
Page 124:
Where the future becomes realityHOT
show all

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Create successful ePaper yourself

Delete template?

Save as template?